Swerdloff, R. S., Amory, J. K., Gittelman, M., Seo, B. W., Rohowsky, N., & Dudley, R. E. (2021). Safety Analysis of an Oral Testosterone Undecanoate (TU) Formulation Following 2 Years of Administration in Hypogonadal Men. J Endocr Soc.
Chicago Stili AlıntıSwerdloff, Ronald S., John K. Amory, Marc Gittelman, B Woun Seo, Nestor Rohowsky, ve Robert E. Dudley. "Safety Analysis of an Oral Testosterone Undecanoate (TU) Formulation Following 2 Years of Administration in Hypogonadal Men." J Endocr Soc 2021.
MLA AlıntıSwerdloff, Ronald S., et al. "Safety Analysis of an Oral Testosterone Undecanoate (TU) Formulation Following 2 Years of Administration in Hypogonadal Men." J Endocr Soc 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..